NeuroGenomics and Informatics Center

Medicine & Life Sciences

1. Alzheimer Disease 100%
2. Genome-Wide Association Study 40%
3. Genes 37%
4. Mutation 28%
5. Amyloid 27%
6. Genome 27%
7. Cerebrospinal Fluid 26%
8. Single Nucleotide Polymorphism 24%
9. Brain 18%
10. Meta-Analysis 14%
11. Biomarkers 14%
12. Frontotemporal Dementia 14%
13. Stroke 13%
14. Alleles 11%
15. Blood Pressure 11%
16. Parkinson Disease 10%
17. Frontotemporal Lobar Degeneration 10%
18. Pathology 10%
19. Cognitive Dysfunction 9%
20. Phenotype 9%
21. Apolipoprotein E4 9%
22. Age of Onset 9%
23. Dementia 8%
24. Exome 8%
25. Endophenotypes 8%
26. Lipids 8%
27. Genetic Variation 8%
28. Tauopathies 8%
29. Genotype 7%
30. Neurodegenerative Diseases 7%
31. Smoking 7%
32. Population 7%
33. Apolipoproteins E 7%
34. Whole Genome Sequencing 7%
35. Genomics 7%
36. African Americans 7%
37. Whole Exome Sequencing 7%
38. Microglia 7%
39. Datasets 7%
40. Progressive Supranuclear Palsy 6%
41. 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole 6%
42. Hydrocephalus 6%
43. Neurons 6%
44. Gene-Environment Interaction 6%
45. White Matter 6%
46. Multifactorial Inheritance 6%
47. Proteins 6%
48. Neuroimaging 5%
49. Induced Pluripotent Stem Cells 5%
50. Gene Expression 5%
51. Progranulins 5%
52. Amyloid beta-Protein Precursor 5%
53. Odds Ratio 5%
54. Cerebral Hemorrhage 5%